US STOCK
ISRG Stock Analysis
US stocks · market data · technical indicators
Intuitive Surgical, Inc.
ISRGUS stocksQuote delayed 15 min
10/27 上午01:02 updated
$450.29
-2.00-0.44%
Open
$451.93
High
$458.88
Low
$449.52
Volume
115.44萬
ISRG price history
+8.88%Open
414.79
Latest
451.63
High
452.29
Low
391.95
Average
422.07
Advertisement
Financial snapshot
ISRG - Intuitive Surgical, Inc.
EPS
8.27USD
Forward EPS
12.43USD
P/E
54.61x
Forward P/E
36.33x
P/B
9.79x
ROE
17.93%
ROA
11.85%
Operating margin
33.29%
Profit margin
25.54%
Revenue growth
21.70%
Earnings growth
-23.60%
Dividend yield
0.00%
Financial statements
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| Revenue | $3.05B | $2.89B | $2.77B | $2.87B | $2.51B |
| Gross profit | $2.08B | $1.96B | $1.83B | $1.90B | $1.66B |
| Operating income | $1.04B | $971.90M | $855.30M | $864.30M | $759.70M |
| Net income | $522.80M | $818.10M | $821.50M | $794.80M | $704.40M |
| Basic EPS | 1.50 | 2.31 | 2.31 | 2.24 | 1.98 |
| Diluted EPS | 1.49 | 2.29 | 2.28 | 2.21 | 1.95 |
Estimates vs actuals
Next earnings
2027-01-21
EPS estimate
2.95
Revenue estimate
$3.23B
Last surprise
+13.61%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2027-01-21 | 2.95 | Not reported | — |
| 2026-10-20 | 2.64 | 3.00 | +13.61% |
| 2026-07-16 | 2.50 | 2.80 | +11.86% |
| 2026-04-21 | 2.11 | 2.50 | +18.67% |
| 2026-01-22 | 2.27 | 2.53 | +11.57% |
| 2025-10-21 | 1.99 | 2.40 | +20.70% |
| 2025-07-22 | 1.92 | 2.19 | +14.08% |
| 2025-04-22 | 1.73 | 1.81 | +4.41% |
| 2025-01-23 | 1.79 | 2.21 | +23.73% |
| 2024-10-17 | 1.64 | 1.84 | +12.25% |
| 2024-07-18 | 1.54 | 1.78 | +15.51% |
| 2024-04-18 | 1.42 | 1.50 | +5.98% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| VANGUARD GROUP INC | 2025-12-31 | $19B | 0.28% |
| BlackRock Inc. | 2024-06-30 | $13.4B | 0.30% |
| STATE STREET CORP | 2026-06-30 | $6.4B | 0.19% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $787.1M | 0.57% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $200.6M | 0.28% |
| CITADEL ADVISORS LLC | 2026-06-30 | $186.9M | 0.02% |
| Bridgewater Associates, LP | 2026-06-30 | $7.7M | 0.03% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$478.30
Target range
$324.00 – $685.00
Implied upside
5.91%
Strong buy
7
Buy
19
Hold
6
Sell
1
Strong sell
1
Advertisement